Gastrointestinal Health News and Research

Latest Gastrointestinal Health News and Research

Women voice frustration over antibiotic use and limited treatment options for UTIs

Women with frequent urinary tract infections say they're unhappy with what they perceive as their doctors' overuse of antibiotics and with the limited treatment options available to them, according to a study led by researchers from UCLA and Cedars-Sinai.

4 Aug 2021

Drug-eluting endotracheal tubes for preventing airway complications

In a proof-of-concept study, researchers at Children's Hospital of Philadelphia have created a coating that can be applied to endotracheal tubes and release antimicrobial peptides that target infectious bacteria with specificity.

4 Aug 2021

Next-Generation Sequencing and the Diagnosis of Disease

In this interview, Professor John Rossen talks about next-generation sequencing and it's implications for the diagnosis of disease.

From Tecan 4 Aug 2021

Research reveals the economic burden of colorectal cancer across Europe

New research led by Queen’s University Belfast has found that colorectal cancer costs Europe a staggering €19.1 billion (£16.3 billion) per year. This figure includes direct expenditure as well as indirect costs including premature death and sick leave.

4 Aug 2021

Diagnosis of viral infections using micro and nanoscale technologies

In a recent study, the authors provide a review on both micro- and nanoscale technologies that advanced the diagnosis of viral diseases.

3 Aug 2021

Flagging potential molecular predictors of response to biological therapies in ulcerative colitis

Several individuals suffering from bowel diseases like ulcerative colitis fail to respond to conventionally used biologic therapies.

3 Aug 2021

Study sheds light on oral vaccine failure in mouse model of chronic gut disorder

A chronic gut disorder that occurs in regions with poor sanitation disrupts intestinal immune responses and impairs oral vaccine effectiveness in a mouse model of the disease, according to research led by UPMC Children's Hospital of Pittsburgh and University of Pittsburgh School of Medicine scientists.

3 Aug 2021

Cancer vaccine reduces tumor burden, improves survival in animal model of Lynch syndrome

A new strategy for developing vaccines against cancer showed promise in a proof-of-concept study led by scientists at Weill Cornell Medicine, NewYork-Presbyterian and Heidelberg University Hospital.

2 Aug 2021

New model can help clinicians to predict 40-day mortality risk in hospitalized COVID-19 patients

Researchers from Hackensack Meridian University Medical Center and Berry Consultants, LLC, Austin, Texas have developed a new model to help clinicians predict the risk of death within 40 days in patients who are hospitalized with COVID-19 infection.

2 Aug 2021

Vitamin D supplements are not effective for easing painful IBS symptoms, study reveals

Vitamin D supplements are not an effective treatment for easing painful symptoms of Irritable Bowel Syndrome (IBS), a new study from the University of Sheffield reveals.

29 Jul 2021

Moderate drinking may be linked with decreased risk of heart attack and death in adults with CVD

Drinking up to 105 grams of alcohol per week - equivalent to 13 UK units of alcohol, less than six pints of medium-strength beer or just over a bottle of wine - may be associated with a decreased risk of heart attack, stroke, angina or death among those with cardiovascular disease (CVD).

27 Jul 2021

Increasing your risk of IBD through processed food

In this interview, News-Medical speaks to Dr. Neeraj Narula about ultra-processed food and how this can increase your risk of developing inflammatory bowel disease(IBD).

27 Jul 2021

UMass Amherst Ph.D. candidate receives USDA-NIFA fellowship for food allergy research

University of Massachusetts Amherst food science Ph.D. candidate Cassandra Suther has received a prestigious predoctoral fellowship of $180,000 from the U.S. Department of Agriculture's National Institute of Food and Agriculture (USDA-NIFA) to study the effect of norovirus on the development and severity of food allergies.

23 Jul 2021

Researchers develop a transferrable and integrative type I CRISPR-based platform to edit superbugs

A research team led by Dr Aixin YAN, Associate Professor from the Research Division for Molecular & Cell Biology, Faculty of Science, in collaboration with Honorary Clinical Professor Patrick CY WOO from the Department of Microbiology, Li Ka Shing Faculty of Medicine, the University of Hong Kong, reported the development of a transferrable and integrative type I CRISPR-based platform.

23 Jul 2021

'Good cholesterol' protects the liver from inflammation and injury, study shows

The body's so-called good cholesterol may be even better than we realize. New research from Washington University School of Medicine in St. Louis suggests that one type of high-density lipoprotein (HDL) has a previously unknown role in protecting the liver from injury.

22 Jul 2021

Human coronaviruses need organic materials to transfer efficiently between surfaces

This study, published in the journal Viruses, indicated that human coronaviruses do not transfer effectively from contaminated hands to contact surfaces without the presence of any organic material.

21 Jul 2021

Maternal fecal transplant may help restore gut microbiota in newborns with diabetes risk

Newborns at risk for Type 1 diabetes because they were given antibiotics may have their gut microorganisms restored with a maternal fecal transplant, according to a Rutgers study.

20 Jul 2021

Redhill Biopharma announces completion of Phase 2/3 COVID-19 study of oral opaganib

RedHill Biopharma Ltd., a specialty pharma company that is a leader in the development of novel oral therapies for COVID-19, today announced that all treatment and follow-up has now been completed in the 475-patient global Phase 2/3 study with opaganib (ABC294640) in patients hospitalized with severe COVID-19 pneumonia (NCT04467840). Top-line results are expected in the coming weeks.

20 Jul 2021

Dysbiosis in gut microbiota may cause severe secondary infection in COVID-19 patients

An interesting study led by scientists in the U.S. has recently revealed that the microbial community in the gut is directly affected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and that virus-mediated gut microbiome dysbiosis may cause severe secondary infections in coronavirus disease 2019 (COVID-19) patients. The study is currently available on the bioRxiv* preprint server.

19 Jul 2021

Researchers isolate human monoclonal antibodies that may neutralize several norovirus variants

Researchers at Vanderbilt University Medical Center and the Baylor College of Medicine in Houston, Texas, have taken a big step toward developing targeted treatments and vaccines against a family of viruses that attacks the gastrointestinal tract.

16 Jul 2021

Gastrointestinal Health News and Research

Latest Gastrointestinal Health News and Research

Women voice frustration over antibiotic use and limited treatment options for UTIs

Drug-eluting endotracheal tubes for preventing airway complications

Next-Generation Sequencing and the Diagnosis of Disease

Research reveals the economic burden of colorectal cancer across Europe

Diagnosis of viral infections using micro and nanoscale technologies

Flagging potential molecular predictors of response to biological therapies in ulcerative colitis

Study sheds light on oral vaccine failure in mouse model of chronic gut disorder

Cancer vaccine reduces tumor burden, improves survival in animal model of Lynch syndrome

New model can help clinicians to predict 40-day mortality risk in hospitalized COVID-19 patients

Vitamin D supplements are not effective for easing painful IBS symptoms, study reveals

Moderate drinking may be linked with decreased risk of heart attack and death in adults with CVD

Increasing your risk of IBD through processed food

UMass Amherst Ph.D. candidate receives USDA-NIFA fellowship for food allergy research

Researchers develop a transferrable and integrative type I CRISPR-based platform to edit superbugs

'Good cholesterol' protects the liver from inflammation and injury, study shows

Human coronaviruses need organic materials to transfer efficiently between surfaces

Maternal fecal transplant may help restore gut microbiota in newborns with diabetes risk

Redhill Biopharma announces completion of Phase 2/3 COVID-19 study of oral opaganib

Dysbiosis in gut microbiota may cause severe secondary infection in COVID-19 patients

Researchers isolate human monoclonal antibodies that may neutralize several norovirus variants

Your full guide to the gut microbiome eBook

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Gastrointestinal Health News and Research

Latest Gastrointestinal Health News and Research

Your full guide to the gut microbiome eBook

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Newsletters you may be interested in